You are here: Industry Insights > cGMP

News List

Syngene expands biopharma-manufacturing capacity expresspharma
August 13, 2021
The company sets up a state-of-the-art microbial facility; expands mammalian facility.
Evotec Opens cGMP Manufacturing Facility in Redmond, WA contractpharma
August 12, 2021
Evotec SE has opened its late-stage clinical and commercial biologics cGMP manufacturing facility (J.POD 1 US) in Redmond, Washington.
Marker Therapeutics Announces Opening of New cGMP Manufacturing Facility americanpharmaceuticalreview
August 02, 2021
Marker Therapeutics, Inc. announced that the Company's new cGMP manufacturing facility in Houston, TX, located near the George Bush Intercontinental Airport, is fully operational.
Kriya Therapeutics Completes Renovation of Its Facility for Scalable Gene Therapy Manufacturing firstwordpharma
July 29, 2021
Kriya Therapeutics, Inc. today announced the completion of the renovation of its 51,000 square foot facility located in Research Triangle Park, North Carolina to support cGMP production of its expanding pipeline of gene therapies.
Marvel Biotechnology Begins cGMP Manufacturing of Lead Candidate contractpharma
July 23, 2021
Marvel Biotechnology has reported a milestone in the development of its lead compound MB-204, entering into a current good manufacturing process (cGMP) manufacturing agreement with Zhejiang Ausun Pharmaceutical.
Catalent Biologics Launches GPEx Lightning Cell Line Expression Technology contractpharma
July 23, 2021
Designed to shorten drug substance development timelines by up to three months.
Thermo Fisher Scientific Launches Heracell Vios CR CO2 Incubator contractpharma
July 22, 2021
First-in-market CO2 incubator combines optimal cell growth capabilities with certified cleanroom compatibility.
GentiBio, Forge Biologics Ink Development and Manufacturing Agreement contractpharma
July 19, 2021
GentiBio and Forge Biologics have entered a development and manufacturing partnership to advance GentiBio’s immune tolerance platform.
Thermo Fisher Scientific Opens New Plasmid DNA Manufacturing Facility contractpharma
July 16, 2021
Thermo Fisher Scientific Inc. has opened a new cGMP plasmid DNA manufacturing facility in Carlsbad, Calif., enabling it to meet rapidly growing demand for plasmid DNA-based therapies and vital mRNA-based vaccines.
Thermo Fisher Scientific opens plasmid DNA manufacturing facility at Carlsbad campus cphi-online
July 16, 2021
67,000-square-foot facility at Carlsbad campus is part of CDMO's investment strategy that addresses growing global demand for cell and gene therapies and vaccines

Previous page 1 2 3 4 5 6 7 8 9 Next page